Strategic Investment Advisors Gilead Sciences, Inc. Transaction History

Strategic Investment Advisors

$909 Million
Q3 2024

A detailed history of Strategic Investment Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Strategic Investment Advisors holds 57,656 shares of GILD stock, worth $5.31 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

57,656

Previous 55,776 3.37%

Holding current value

$5.31 Million

Previous $3.83 Million 26.29%

% of portfolio

0.53%

Previous 0.47%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$66.59 - $83.99 $125,189 - $157,901	1,880 Added 3.37%	57,656 $4.83 Million
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $24,502 - $28,277	-388 Reduced 0.69%	55,776 $3.83 Million
Q1 2024 Apr 22, 2024	BUY	$71.58 - $87.29 $122,688 - $149,615	1,714 Added 3.15%	56,164 $4.11 Million
Q4 2023 Jan 10, 2024	SELL	$73.27 - $83.09 $136,648 - $154,962	-1,865 Reduced 3.31%	54,450 $4.41 Million
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $248,068 - $270,647	3,355 Added 6.33%	56,315 $4.22 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $1.73 Million - $1.97 Million	22,773 Added 75.44%	52,960 $4.08 Million
Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $355,935 - $405,520	4,604 Added 18.0%	30,187 $2.5 Million
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $68,552 - $98,417	-1,100 Reduced 4.12%	25,583 $0
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $100,741 - $115,072	1,692 Added 6.77%	26,683 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $13,737 - $15,472	238 Added 0.96%	24,991 $1.55 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $530,547 - $664,832	9,160 Added 58.74%	24,753 $1.47 Million
Q4 2021 Jan 26, 2022	BUY	$64.88 - $73.64 $1.01 Million - $1.15 Million	15,593 New	15,593 $1.13 Million
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $269,993 - $307,645	-4,766 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $71,415 - $89,792	1,150 Added 31.8%	4,766 $301,000
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $205,011 - $238,056	-2,834 Reduced 43.94%	3,616 $278,000
Q1 2020 Apr 13, 2020	BUY	$62.63 - $80.22 $89,059 - $114,072	1,422 Added 28.28%	6,450 $482,000
Q4 2019 Jan 23, 2020	BUY	$61.62 - $67.78 $13,802 - $15,182	224 Added 4.66%	5,028 $327,000
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $300,298 - $331,476	4,804 New	4,804 $304,000

Others Institutions Holding GILD

# of Institutions

1,917

Shares Held

995M

Call Options Held

10.1M

Put Options Held

9.46M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Account

Strategic Investment Advisors Gilead Sciences, Inc. Transaction History